Terms: = Thyroid cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25
29 results:
1. Pleckstrin homology and RhoGEF domain containing G4 (PLEKHG4) leads to the activation of RhoGTPases promoting the malignant phenotypes of thyroid cancer.
Yuan Q; Fan Y; Liu Z; Wang X; Jia M; Dong Y; Geng Z; Zheng J; Lu X
Apoptosis; 2023 Oct; 28(9-10):1315-1331. PubMed ID: 37336836
[TBL] [Abstract] [Full Text] [Related]
2. The potential diagnostic value of rac1 immunohistochemistry in follicular thyroid carcinoma.
Agustina H; Ahyati R; Suryanti S; Hernowo BS
Malays J Pathol; 2022 Aug; 44(2):225-233. PubMed ID: 36043585
[TBL] [Abstract] [Full Text] [Related]
3. Dsg2-mediated c-Met activation in anaplastic thyroid cancer motility and invasion.
Lee K; Lee SH; Kim W; Lee J; Park JG; Kim JS; Kim JT; Kang YE; Shong M; Lee HJ; Kim JM; Kim WG; Koo BS; Kim KS; Min JK
Endocr Relat Cancer; 2020 Nov; 27(11):601-614. PubMed ID: 33022637
[TBL] [Abstract] [Full Text] [Related]
4. Molecular therapeutics for anaplastic thyroid cancer.
Pozdeyev N; Rose MM; Bowles DW; Schweppe RE
Semin Cancer Biol; 2020 Apr; 61():23-29. PubMed ID: 31991166
[TBL] [Abstract] [Full Text] [Related]
5. Antagonistic effects of rac1 and tumor-related rac1b on NIS expression in thyroid.
Faria M; Félix D; Domingues R; Bugalho MJ; Matos P; Silva AL
J Mol Endocrinol; 2019 Nov; 63(4):309-320. PubMed ID: 31590142
[TBL] [Abstract] [Full Text] [Related]
6. KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary thyroid cancer.
Owen DH; Konda B; Sipos J; Liu T; Webb A; Ringel MD; Timmers CD; Shah MH
J Natl Compr Canc Netw; 2019 May; 17(5):409-413. PubMed ID: 31085763
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
[TBL] [Abstract] [Full Text] [Related]
8. Ginsenoside Rg3 Inhibition of thyroid cancer Metastasis Is Associated with Alternation of Actin Skeleton.
Wu W; Zhou Q; Zhao W; Gong Y; Su A; Liu F; Liu Y; Li Z; Zhu J
J Med Food; 2018 Sep; 21(9):849-857. PubMed ID: 30136914
[TBL] [Abstract] [Full Text] [Related]
9. Upregulated hsa_circ_0004458 Contributes to Progression of Papillary thyroid Carcinoma by Inhibition of miR-885-5p and Activation of rac1.
Jin X; Wang Z; Pang W; Zhou J; Liang Y; Yang J; Yang L; Zhang Q
Med Sci Monit; 2018 Aug; 24():5488-5500. PubMed ID: 30086127
[TBL] [Abstract] [Full Text] [Related]
10. Genetic Analysis of 779 Advanced Differentiated and Anaplastic thyroid cancers.
Pozdeyev N; Gay LM; Sokol ES; Hartmaier R; Deaver KE; Davis S; French JD; Borre PV; LaBarbera DV; Tan AC; Schweppe RE; Fishbein L; Ross JS; Haugen BR; Bowles DW
Clin Cancer Res; 2018 Jul; 24(13):3059-3068. PubMed ID: 29615459
[No Abstract] [Full Text] [Related]
11. Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/β-catenin signaling.
Liu L; Wu B; Cai H; Li D; Ma Y; Zhu X; Lv Z; Fan Y; Zhang X
Exp Cell Res; 2018 Jan; 362(2):532-540. PubMed ID: 29277502
[TBL] [Abstract] [Full Text] [Related]
12. Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic thyroid cancer.
Chen MC; Tsai YC; Tseng JH; Liou JJ; Horng S; Wen HC; Fan YC; Zhong WB; Hsu SP
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236027
[TBL] [Abstract] [Full Text] [Related]
13. An anti-cancer WxxxE-containing azurin polypeptide inhibits rac1-dependent STAT3 and ERK/GSK-3β signaling in breast cancer cells.
Zhang Z; Luo Z; Min W; Zhang L; Wu Y; Hu X
Oncotarget; 2017 Jun; 8(26):43091-43103. PubMed ID: 28549350
[TBL] [Abstract] [Full Text] [Related]
14. rac1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells.
Faria M; Matos P; Pereira T; Cabrera R; Cardoso BA; Bugalho MJ; Silva AL
PLoS One; 2017; 12(2):e0172689. PubMed ID: 28234980
[TBL] [Abstract] [Full Text] [Related]
15. Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma.
Tanabe K; Shinsato Y; Furukawa T; Kita Y; Hatanaka K; Minami K; Kawahara K; Yamamoto M; Baba K; Mori S; Uchikado Y; Maemura K; Tanimoto A; Natsugoe S
Oncotarget; 2017 Jan; 8(4):6353-6363. PubMed ID: 28031525
[TBL] [Abstract] [Full Text] [Related]
16. EphB3 Stimulates Cell Migration and Metastasis in a Kinase-dependent Manner through Vav2-Rho GTPase Axis in Papillary thyroid cancer.
Li JJ; Sun ZJ; Yuan YM; Yin FF; Bian YG; Long LY; Zhang XL; Xie D
J Biol Chem; 2017 Jan; 292(3):1112-1121. PubMed ID: 27986811
[TBL] [Abstract] [Full Text] [Related]
17. Collective cell migration of thyroid carcinoma cells: a beneficial ability to override unfavourable substrates.
Lobastova L; Kraus D; Glassmann A; Khan D; Steinhäuser C; Wolff C; Veit N; Winter J; Probstmeier R
Cell Oncol (Dordr); 2017 Feb; 40(1):63-76. PubMed ID: 27826898
[TBL] [Abstract] [Full Text] [Related]
18. Expression of tumor-related rac1b antagonizes B-Raf-induced senescence in colorectal cells.
Henriques AF; Barros P; Moyer MP; Matos P; Jordan P
Cancer Lett; 2015 Dec; 369(2):368-75. PubMed ID: 26341689
[TBL] [Abstract] [Full Text] [Related]
19. MMP2 and MMP9 participate in S1P-induced invasion of follicular ML-1 thyroid cancer cells.
Kalhori V; Törnquist K
Mol Cell Endocrinol; 2015 Mar; 404():113-22. PubMed ID: 25643979
[TBL] [Abstract] [Full Text] [Related]
20. rac1b overexpression in papillary thyroid carcinoma: a role to unravel.
Silva AL; Carmo F; Bugalho MJ
Eur J Endocrinol; 2013 Jun; 168(6):795-804. PubMed ID: 23482591
[TBL] [Abstract] [Full Text] [Related]
[Next]
